ARCHIVES

FDA to refer false statements by regulated companies to SEC.

This article is from The Cancer Letter archive.

Vol. 30 No. 09 | February 27, 2004

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Working Group Offers 21 Recommendations to improve efficiency of trials.

February 25, 2005

Becker, Jako, Epstein Wrangle Over Basic Research, ‘Cancer Establishment’

May 15, 1992

In Brief: ACS to support $2 Billion NCI Budget; NCAB Backs Minority Enhancement Core Supplements

February 19, 1988

Brothers Of Prostate Cancer Patients At Risk Of Diagnosis

August 27, 2010

Fisher To Direct Wilmot CC

October 5, 2001

Brown’s appointment may Be Delayed Until After Jan. 20

January 14, 1977